Researchers have found that combining tolerogenic dendritic cells with Dimethyl Fumarate improves treatment efficacy for multiple sclerosis, offering a promising new approach for managing the disease. Multiple sclerosis (MS) is a chronic condition in which the immune system erroneously assaults the myelin sheath, the protective coating around nerve cells, leading to nerve damage and increased […]
Source link